Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. - Wikidata - wikimedia - TriplyDB

Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

http://www.wikidata.org/entity/Q43036230

about

Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung Crystal Structure of the Coat Protein of the Flexible Filamentous Papaya Mosaic Virus Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles Classification and characterization of therapeutic antibody aggregates.Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.Plant-based vaccines against viruses.A novel M2e based flu vaccine formulation for dogs.Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin Potato Virus M-Like Nanoparticles: Construction and Characterization.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Immune response to a potyvirus with exposed amino groups available for chemical conjugation.Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine.Coupling Peptide Antigens to Virus-Like Particles or to Protein Carriers Influences the Th1/Th2 Polarity of the Resulting Immune Response.Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.Immune responses during acute and chronic infection with hepatitis C virus.Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines.Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.Prospects for prophylactic hepatitis C vaccines based on virus-like particles In planta production of plant-derived and non-plant-derived adjuvants.Adjuvanted influenza vaccines.Virus-like particle-based vaccines against hepatitis C virus infection.Immunogenicity of therapeutic proteins: influence of aggregation.Virus-based nanoparticles as platform technologies for modern vaccines.Synthetic plant virology for nanobiotechnology and nanomedicine Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP.Characterization of Alternanthera mosaic virus and its Coat Protein.Reconceptualizing cancer immunotherapy based on plant production systems.Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus.Nanostructural characterization of Sf9 cells during virus-like particles generation.Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus-like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative.

P2860

Q26782569-EC1ECFE0-DD15-4352-8D44-50036995CD6D Q26801759-5F198EFF-F8B0-4968-8CA1-CE385D748708 Q26825031-0EC5C7C4-6408-41CB-BE19-093AA74BB4B7 Q27679448-B9CBAAF0-2308-4D82-BA76-4CBF30A777AF Q28731876-214587C4-BC4F-4288-8A35-FF3779773426 Q28743086-E1753DB5-DDEA-4A7E-BAFE-90FB86709590 Q30502491-99414F70-442E-4CAD-B859-3CDF81DABD81 Q33517131-639F1F9A-ED5F-4211-A205-FC3C6085CB53 Q33916892-D4CCDF2F-6170-4C4F-BED0-F298770A738F Q34687464-7522055F-83BD-43DC-A3AF-31C8001D225A Q35009732-3E34F900-FC83-4018-97FC-617446A435FB Q35345853-14EE8A1C-0E72-46A3-AF2A-F7324B44A973 Q35749381-8302F0D0-0212-4D85-9CFB-3D7092AB094B Q35766278-39F0A8A3-3B92-4415-BFC1-CAE48015512A Q35854131-D595D547-AFFB-4866-9331-DDDB794FE70E Q35984242-4CC57D93-E2D5-47C6-ABBA-24DE735226BE Q36126960-D19B7C2C-041A-4A36-8504-95075F3B7319 Q36186712-C2202E57-E1C9-4FAD-99E2-A28485D3853A Q36424493-F9A825B8-55FD-4CA8-A091-4B5B099945B9 Q36569534-55707A05-B299-49AD-8034-43D8165910D4 Q36991329-C8CA4FD5-42B8-480A-A986-715FD27B56D6 Q37061930-3B83422F-7130-4605-92CC-78BA216CB812 Q37077649-24DD0E4B-F523-4C6E-81DF-73D62AA51246 Q37178225-53D6FFC0-D28C-47A4-868F-7F265D4B241F Q37312793-EC639DA1-CE3C-4AFA-9C5A-78A2684C0CBB Q37347267-3426206D-EAD8-401F-978B-964227373206 Q37505405-B234189D-7669-436A-A077-E7FEE975A0D3 Q37776716-3515BEEF-669C-4462-AB87-B89EA2A659F5 Q37976540-379ADADB-4BAE-4C43-B7B9-5D4161DD1F74 Q38081966-EB4DB236-A3C1-48A7-8BD2-BEF5C818EA79 Q38126938-B30F7231-C60B-4628-BA24-CC02DCCBFF90 Q38702017-9A0D117E-9B01-430E-8DC3-96F6AB5DBFB4 Q39081725-907CFDD6-2ED2-4C8C-A4C8-D6E643245E97 Q39709538-7CCDA1DF-2EF1-457C-BF4B-5F898B415BB9 Q39979467-217F7366-B4B3-49EE-9E82-D84EA52CF652 Q40051873-98518B62-D0FA-4919-B136-2AF45C6A7D98 Q40187606-A04E9E0B-9FEC-4766-A4DC-6E215F545284 Q40432402-A1F23FD8-3B3D-4CE7-96B9-040D4DDF06C4 Q40700617-551B4B05-6CD7-4A8C-8C5F-F2C4BD785B69 Q40758012-2B5C2750-BE9F-49C6-BA01-E5CAD068E9A5

P2860

Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

http://www.wikidata.org/entity/Q43036230

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Immunogenicity of papaya mosai ...... l function of multimerization.

@en

Immunogenicity of papaya mosai ...... l function of multimerization.

@nl

type

label

Immunogenicity of papaya mosai ...... l function of multimerization.

@en

Immunogenicity of papaya mosai ...... l function of multimerization.

@nl

prefLabel

Immunogenicity of papaya mosai ...... l function of multimerization.

@en

Immunogenicity of papaya mosai ...... l function of multimerization.

@nl

P1433

Q43036230-3FC47778-7802-4D23-B485-B619DA9DF971

P1476

Q43036230-20DC6DE4-0C54-4F4D-8917-306F89C44CD9

P2093

Q43036230-14B5E435-C977-4C13-BA79-381A4C85D683

Q43036230-1651BCBB-62BE-40A0-B92C-3D0060CA1E8A

Q43036230-18B8A255-1530-4B9E-8F08-20B47ECC6909

Q43036230-2DC19B9E-204B-4898-8161-EF5954837FCF

Q43036230-37C4D2B3-DAF6-495B-8D52-8CAA3A84AE52

Q43036230-3C237DDD-F923-4D75-A3F5-52FEB907BE9D

Q43036230-405E3F52-303F-4C8F-909A-6DF19F75FE1E

Q43036230-5FA2BF40-FD9E-479E-B1F1-8FE5F9E4129E

Q43036230-7E09606D-E2FC-4789-821C-DD2EFAA07E68

Q43036230-871637E9-C40E-4A97-920A-1E8C939B3530

P304

Q43036230-AAB6699E-345F-44AC-8D10-4824720607CF

P31

Q43036230-044D6E93-1419-4B7B-B5FD-CF047E734B43

P356

Q43036230-882FEECC-F1C4-40BE-8F11-A8AD07C66AEE

P407

Q43036230-FF85437E-EAC8-4346-864C-F0329A9C6EFE

P433

Q43036230-19AB45D9-8E54-4FB8-909E-F6CEE0575B8B

P478

Q43036230-334E3CEF-3CC2-46AE-A986-BBA86220B921

P50

Q43036230-21554A4D-3A96-4AB1-AA94-CD8F72601A00

Q43036230-34AFA607-E349-4F12-80D4-8A6118C8A6EA

Q43036230-43BCB7A4-16A8-44B4-B34B-E4FDE7E679B5

P577

Q43036230-60F67C84-ED60-4B74-844A-F5941BACCB9E

P5875

Q43036230-2B52C26D-6E91-4D74-885A-C5EAE059BBFA

P698

Q43036230-B0172530-1942-431E-8763-8811347C02B7

P356

J.VIROL.2007.01.011

P1433

P1476

Immunogenicity of papaya mosai ...... al function of multimerization

@en

P2093

Alain Lamarre

http://www.w3.org/2001/XMLSchema#string

Bernard Willems

http://www.w3.org/2001/XMLSchema#string

Christian Savard

http://www.w3.org/2001/XMLSchema#string

Christine Pare

http://www.w3.org/2001/XMLSchema#string

Denis Leclerc

http://www.w3.org/2001/XMLSchema#string

Elizabeth Acosta-Ramirez

http://www.w3.org/2001/XMLSchema#string

Jérôme Denis

http://www.w3.org/2001/XMLSchema#string

Katia Lecours

http://www.w3.org/2001/XMLSchema#string

Marie-Claude Bedard

http://www.w3.org/2001/XMLSchema#string

Marilène Bolduc

http://www.w3.org/2001/XMLSchema#string

P304

59-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2007.01.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Tessier

Constatino III Roberto López Macías

C López-Macías

P577

2007-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6486433

http://www.w3.org/2001/XMLSchema#string

P698

17320136

http://www.w3.org/2001/XMLSchema#string